ACXPAcurx Pharmaceuticals, Inc.

Nasdaq www.acurxpharma.com


$ 2.01 $ 0.02 (1.01 %)    

Thursday, 12-Sep-2024 15:59:00 EDT
QQQ $ 472.99 $ 4.60 (0.98 %)
DIA $ 411.97 $ 2.70 (0.66 %)
SPY $ 558.49 $ 4.67 (0.84 %)
TLT $ 100.12 $ -0.47 (-0.47 %)
GLD $ 236.34 $ 4.08 (1.76 %)
$ 2.01
$ 2.01
$ 1.99 x 300
$ 2.01 x 100
$ 2.01 - $ 2.02
$ 1.17 - $ 8.82
16,213
na
32.65M
$ 0.03
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 03-15-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-11-2023 06-30-2023 10-Q
6 05-12-2023 03-31-2023 10-Q
7 03-15-2023 12-31-2022 10-K
8 11-10-2022 09-30-2022 10-Q
9 08-12-2022 06-30-2022 10-Q
10 05-10-2022 03-31-2022 10-Q
11 03-16-2022 12-31-2021 10-K
12 11-12-2021 09-30-2021 10-Q
13 08-13-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-acurx-pharmaceuticals-maintains-12-price-target

HC Wainwright & Co. analyst Ed Arce reiterates Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and maintains $12 price ta...

 acurx-pharmaceuticals-q2-2024-gaap-eps-026-misses-021-estimate

Acurx Pharmaceuticals (NASDAQ:ACXP) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate ...

 hc-wainwright--co-reiterates-buy-on-acurx-pharmaceuticals-maintains-12-price-target

HC Wainwright & Co. analyst Ed Arce reiterates Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and maintains $12 price ta...

 acurx-reports-outcome-of-fda-end-of-phase-2-meeting-and-phase-3-readiness-for-ibezapolstat-for-treatment-of-c-difficile-infection

Agreement with FDA reached on key elements to move forward with our international Phase 3 clinical trial programAgreement also ...

 acurx-pharmaceuticals-q1-2024-gaap-eps-028-misses-024-estimate

Acurx Pharmaceuticals (NASDAQ:ACXP) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate ...

 why-alcoa-shares-are-trading-higher-here-are-20-stocks-moving-premarket

Shares of Alcoa Corporation (NYSE: AA) rose sharply in today’s pre-market trading after the company reported better-than-expec...

 hc-wainwright--co-maintains-buy-on-acurx-pharmaceuticals-lowers-price-target-to-12

HC Wainwright & Co. analyst Ed Arce maintains Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and lowers the price target...

 acurx-pharmaceuticals-q4-eps-037-misses-026-estimate

Acurx Pharmaceuticals (NASDAQ:ACXP) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate ...

 earnings-scheduled-for-march-18-2024

Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to report earnings for its fourth quarter.

 hc-wainwright--co-reiterates-buy-on-acurx-pharmaceuticals-maintains-14-price-target

HC Wainwright & Co. analyst Ed Arce reiterates Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and maintains $14 price ta...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION